Factors influencing outcome and treatment effect in PROACT II

Stroke

Volumn 34, Issue 5, 2003, Pages 1224-1229

  Wechsler, Lawrence R ^a,l   Roberts, Robin ^b   Furlan, Anthony J ^c   Higashida, Randall T ^d   Dillon, William ^d   Roberts, Heidi ^e   Rowley, Howard A ^f   Pettigrew, L Creed ^g   Callahan III, Alfred S ^h   Bruno, Askiel ⁱ   Fayad, Pierre ^j   Smith, Wade S ^d   Firszt, Carolyn M ^k   Schulz, Gregory A ^k  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h CENTENNIAL MEDICAL CENTER   (United States)

ⁱ INDIANA UNIVERSITY   (United States)

^j UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^k ABBOTT LABORATORIES   (United States)

^l UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

more..

Author keywords

Outcome; Stroke, acute; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT; PROUROKINASE;

ADULT; AGE; AGED; ANGIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; PRIORITY JOURNAL; PROGNOSIS; RADIOLOGY; RISK FACTOR; STROKE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CEREBRAL ANGIOGRAPHY; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRA-ARTERIAL; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRODRUGS; PROGNOSIS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RISK; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR;

EID: 0037628968     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000068782.15297.28     Document Type: Article

References (22)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Ezura M, Kagawa S. Selective and superselective infusion of urokinase for embolic stroke. Surg Neurol. 1992;38:353-358.
3. Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-tPA). Neuroradiology. 1993;35:159-162.
4. Barnwell SL, Clark WM, Nguyen TT, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. Am J Neuroradiol. 1994;15:1817-1822.
5. Higashida RT, Halbach VV, Barnwell SL, Dowd CF, Hieshima GB. Thrombolytic therapy in acute stroke. J Endovasc Surg. 1994;1:4-15.
6. Sasaki O, Takeuchi S, Koike T, Koizumi T, Tanaka R. Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches. Neurosurgery. 1995;36:246-252; discussion 252-253.
7. del Zoppo GJ, Ferbert A, Otis S, Bruckmann H, Hacke W, Zyroff J, Harker LA, Zeumer H. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke. 1988;19:307-313.
8. Suarez JI, Sunshine JL, Tarr R, Zaidat O, Selman WR, Kernich C, Landis DM. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999;30:2094-2100.
9. Edwards MT, Murphy MM, Geraghty JJ, Wulf JA, Konzen JP. Intra-arterial cerebral thrombolysis for acute ischemic stroke in a community hospital. Am J Neuroradiol. 1999;20:1682-1687.
10. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M, PROACT. A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29:4-11.
11. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA. 1999;282:2003-2011.
12. Pagano M, Gauvreau K. Principles of Biostatistics. Pacific Grove, Calif: Duxbury; 2000:292-293.
13. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA stroke trial. Stroke. 1997;28:2119-2125.
14. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993;24:35-41.
15. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
16. Ueda T, Sakaki S, Kumon Y, Ohta S. Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999;30:2360-2365.
17. Brandt T, von Kummer R, Muller-Kuppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion: variables affecting recanalization and outcome. Stroke. 1996;27:875-881.
18. Gonner F, Remonda L, Mattle H, Sturzenegger M, Ozdoba C, Lovblad KO, Baumgartner R, Bassetti C, Schroth G. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke. 1998;29:1894-1900.
19. Arnold M, Schroth G, Nedeltchev K, Loher T, Remonda L, Stepper F, Sturzenegger M, Mattle HP. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke. 2002;33:1828-1833.
20. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000;55:1649-1655.
21. Patel SC, Levine SR, Tilley BC, Grotta JC, Lu M, Frankel M, Haley EC Jr, Brott TG, Broderick JP, Horowitz S, et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA. 2001;286:2830-2838.
22. Kase CS, Furlan AJ, Wechsler LR, Higashida RT, Rowley HA, Hart RG, Molinari GF, Frederick LS, Roberts HC, Gebel JM, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology. 2001;57:1603-1610.